Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

by Piscitelli, Stephen C , Lebwohl, Mark G , Rubenstein, David S , Guenthner, Scott , Tallman, Anna M , Kircik, Leon , Ehst, Benjamin , Papp, Kim A , Bagel, Jerry , Strober, Bruce , Armstrong, April W , Brown, Philip M , Bissonnette, Robert , Hong, H. Chih-ho , Fromowitz, Jeff , Soung, Jennifer , Stein Gold, Linda

in Adult / Adverse events / Allergy / Anti-Inflammatory Agents, Non-Steroidal - administration & dosage / Anti-Inflammatory Agents, Non-Steroidal - adverse effects / Antioxidants / Autoimmune Disease / Autoimmune diseases / Clinical Practice / Clinical trials / Contact dermatitis / Cytokines / Dermatitis / Dermatitis, Contact - etiology / Dermatology / Disease / Double-Blind Method / Female / Filaggrin / Folliculitis / Headache / Headache - chemically induced / Hospitalist / Humans / Hydrocarbons / Immunology / Intention to Treat Analysis / Interleukin 17 / Interleukin-17 - metabolism / Male / Middle Aged / Patient Reported Outcome Measures / Patient satisfaction / Patients / Primary Care / Pruritus / Psoriasis / Psoriasis - complications / Psoriasis - drug therapy / Quality of life / Receptors, Aryl Hydrocarbon - drug effects / Receptors, Aryl Hydrocarbon - metabolism / Resorcinols - administration & dosage / Resorcinols - adverse effects / Respiratory tract diseases / Rhinopharyngitis / Severity of Illness Index / Skin care products / Skin Cream - administration & dosage / Stilbenes - administration & dosage / Stilbenes - adverse effects / Surface area / Transcription factors

2021

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

2021

Confirm

Do you wish to request the book?

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

2021

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

Piscitelli, Stephen C,

Lebwohl, Mark G,

Rubenstein, David S,

Guenthner, Scott,

Tallman, Anna M,

Kircik, Leon,

Ehst, Benjamin,

Papp, Kim A,

Bagel, Jerry,

Strober, Bruce,

Armstrong, April W,

Brown, Philip M,

Bissonnette, Robert,

Hong, H. Chih-ho,

Fromowitz, Jeff,

Soung, Jennifer,

Stein Gold, Linda

2021

Overview

In two identical trials of treatment for psoriasis with the topical aryl hydrocarbon receptor–modulating agent tapinarof, clearance or near-clearance of lesions occurred in a larger proportion of patients who used tapinarof cream than of those who used placebo. Side effects included folliculitis, contact dermatitis, and headache.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Adult

/ Adverse events

/ Allergy

/ Anti-Inflammatory Agents, Non-Steroidal - administration & dosage

/ Anti-Inflammatory Agents, Non-Steroidal - adverse effects

/ Antioxidants

/ Autoimmune Disease